Open Orphan PLC (AIM:ORPH, OTC:OPORF)’s CEO, Yamin ‘Mo’ Khan says it was a busy and successful first half with record orders, US laboratory services certification and soaring revenues.
Khan, who joined the business in February this year, told Chris Rhodes he is confident of hitting this year's £19mln revenue target, but says there are also lots of other initiatives underway.
The company is also planning a name change to hVIVO, which is what most of its customers know it as, he explains.